ONCOLYTICS BIOTECH INC's ticker is ONCYF and the CUSIP is 682310107. A total of 40 filers reported holding ONCOLYTICS BIOTECH INC in Q2 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $253,000 | -29.9% | 196,749 | -1.4% | 0.00% | -50.0% |
| Q1 2014 | $361,000 | -73.2% | 199,549 | -76.8% | 0.00% | -71.4% |
| Q4 2013 | $1,345,000 | -35.8% | 860,749 | -0.3% | 0.01% | -41.7% |
| Q3 2013 | $2,094,000 | -38.9% | 863,400 | -27.7% | 0.02% | -40.0% |
| Q2 2013 | $3,428,000 | – | 1,194,233 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUITY INVESTMENT MANAGEMENT INC | 11,157,006 | $27,056,000 | 3.70% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 731,157 | $1,784,000 | 0.22% |
| SPROTT INC. | 230,000 | $561,000 | 0.06% |
| VSR Financial Services, Inc. | 106,500 | $260,000 | 0.04% |
| 1832 Asset Management L.P. | 2,684,000 | $6,514,000 | 0.03% |
| AGF INVESTMENTS INC. | 863,400 | $2,094,000 | 0.02% |
| CANADA PENSION PLAN INVESTMENT BOARD | 700,105 | $1,703,000 | 0.01% |
| BANK OF MONTREAL /CAN/ | 1,631,269 | $3,980,000 | 0.01% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 50,000 | $122,000,000 | 0.00% |
| First Eagle Investment Management, LLC | 427,200 | $1,042,000 | 0.00% |